226 related articles for article (PubMed ID: 12867477)
1. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin.
Mongodin E; Finan J; Climo MW; Rosato A; Gill S; Archer GL
J Bacteriol; 2003 Aug; 185(15):4638-43. PubMed ID: 12867477
[TBL] [Abstract][Full Text] [Related]
2. Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation.
Fox PM; Climo MW; Archer GL
Antimicrob Agents Chemother; 2007 Apr; 51(4):1274-80. PubMed ID: 17242154
[TBL] [Abstract][Full Text] [Related]
3. Role of the
G C B; Sahukhal GS; Elasri MO
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
[No Abstract] [Full Text] [Related]
4. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Neoh HM; Cui L; Yuzawa H; Takeuchi F; Matsuo M; Hiramatsu K
Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
[TBL] [Abstract][Full Text] [Related]
5. Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus.
Mirani ZA; Jamil N
J Infect Chemother; 2013 Feb; 19(1):24-33. PubMed ID: 22821354
[TBL] [Abstract][Full Text] [Related]
6. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
[TBL] [Abstract][Full Text] [Related]
7. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
8. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
[TBL] [Abstract][Full Text] [Related]
9. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.
Qureshi NK; Yin S; Boyle-Vavra S
PLoS One; 2014; 9(1):e85873. PubMed ID: 24454941
[TBL] [Abstract][Full Text] [Related]
10. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
12. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
Asadpour L; Ghazanfari N
Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate
Tan XE; Neoh HM; Cui L; Hiramatsu K; Jamal R
Can J Microbiol; 2019 Aug; 65(8):623-628. PubMed ID: 31063703
[TBL] [Abstract][Full Text] [Related]
14. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
[TBL] [Abstract][Full Text] [Related]
15. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
16. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.
Saravolatz LD; Pawlak J; Johnson LB
Clin Infect Dis; 2012 Aug; 55(4):582-6. PubMed ID: 22615331
[TBL] [Abstract][Full Text] [Related]
18. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
Matsuo M; Hishinuma T; Katayama Y; Cui L; Kapi M; Hiramatsu K
Antimicrob Agents Chemother; 2011 Sep; 55(9):4188-95. PubMed ID: 21746940
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin.
Herrera M; Di Gregorio S; Fernandez S; Posse G; Mollerach M; Di Conza J
Ann Clin Microbiol Antimicrob; 2016 Mar; 15():15. PubMed ID: 26956508
[TBL] [Abstract][Full Text] [Related]
20. Concentration dependent exposure of vancomycin and teicoplanin induces vanG regulon in Staphylococcus aureus.
Hazarika M; Wangkheimayum J; Nath K; Singha KM; Chanda DD; Bhattacharjee A
Indian J Med Microbiol; 2024; 48():100563. PubMed ID: 38518847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
